Risk factors and outcome among a large patient cohort with community-acquired acute hepatitis C in Italy

Clinical Infectious Diseases

Volumn 43, Issue 9, 2006, Pages 1154-1159

  Santantonio, Teresa ^a   Medda, E ^b   Ferrari, C ^e   Fabris, P ^f   Cariti, G ^g   Massari, M ^h   Babudieri, S ⁱ   Toti, M ^j   Francavilla, R ^k   Ancarani, F ^l   Antonucci, G ^c   Scotto, G ^m   Di Marco, V ⁿ   Pastore, G ^a   Stroffolini, T ^d  

^a UNIVERSITY OF BARI   (Italy)

^b ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^c NATIONAL INSTITUTE FOR INFECTIOUS DISEASES L SPALLANZANI   (Italy)

^d San Giacomo Hospital   (Italy)

^e UNIVERSITY OF PARMA   (Italy)

^f SAN BORTOLO HOSPITAL   (Italy)

^g UNIVERSITY OF TURIN   (Italy)

^h S MARIA NUOVA HOSPITAL   (Italy)

ⁱ UNIVERSITY OF SASSARI   (Italy)

^j Grosseto Hospital   (Italy)

^k Bisceglie Hospital   (Italy)

^l UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^m UNIVERSITY OF FOGGIA   (Italy)

ⁿ UNIVERSITY OF PALERMO   (Italy)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; BILIRUBIN; VIRUS RNA;

ACUTE HEPATITIS; ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD TRANSFUSION; COMMUNICABLE DISEASE; DEMOGRAPHY; DIALYSIS; ENDOSCOPY; FEMALE; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HOSPITALIZATION; HUMAN; INTRAVENOUS DRUG ABUSE; ITALY; LIVER FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; NEEDLESTICK INJURY; PRIORITY JOURNAL; RISK FACTOR; SEROCONVERSION; SEXUAL INTERCOURSE; STATISTICAL ANALYSIS; SURGICAL PATIENT; TATTOOING; VIRUS DETECTION; VIRUS TRANSMISSION; ACUTE DISEASE; ISOLATION AND PURIFICATION; MIDDLE AGED; VIROLOGY;

ACUTE DISEASE; ADULT; COMMUNITY-ACQUIRED INFECTIONS; FEMALE; HEPACIVIRUS; HEPATITIS C; HUMANS; ITALY; MALE; MIDDLE AGED; RISK FACTORS;

EID: 33750117419     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/507640     Document Type: Article

References (17)

1. Mele A, Stroffolini T, Catapani R, et al. Incidence of transfusion associated B and non-A, non-B hepatitis in Italy. BMJ 1995; 311:846-7.
2. Kim WR. The burden of hepatitis C in the United States. Hepatology 2002; 36:S30-4.
3. Mele A, Tosti ME, Spada E, Kondili L, Marzolini F. SEIEVA (sistema epidemiologico integrato delle epatiti virali acute). Rapporti ISTISAN. Available at: http://www.epicentro.iss.it/problemi/epatite/epatiti.pdf. Accessed 21 September 2006.
4. Tosti ME, Solinas S, Prati D, et al. An estimate of the current risk of transmitting blood-borne infections through blood transfusion in Italy. Br J Haematol 2002; 117:215-9.
5. Kondili LA, Chionne P, Costantino A, et al. Infection rate and spontaneous seroreversion of anti-hepatitis C virus during the natural course of hepatitis C virus infection in the general population. Gut 2002; 50:693-6.
6. Mondelli MU, Cerino A, Cividini A. Acute hepatitis C: diagnosis and management. J Hepatol 2005; 42:5108-14.
7. Jaeckel E, Cornberg M, Wedemeyer H, et al. Treatment of acute hepatitis C with interferon alfa-2b. N Engl J Med 2001; 345:1452-7.
8. Santantonio T, Fasano M, Sinisi E, et al. Efficacy of a 24-week course of peg-interferon α-2b monotherapy in patients with acute hepatitis C after failure of spontaneous clearance. J Hepatol 2005; 42:329-33.
9. Mele A, Tosti ME, Marzolini A, et al. Prevention of hepatitis C in Italy: lessons from surveillance of type-specific acute viral hepatitis. J Viral Hepat 2000; 7:30-5.
10. Gerlach JT, Diepolder HM, Zachoval R, et al. Acute hepatitis C: high rate of both spontaneous and treatment induced viral clearance in symptomatic patients. Gastroenterology 2003; 125:80-8.
11. Delwaide J, Bourgeois N, Gerard C, et al. Treatment of acute hepatitis C with interferon α-2b: early initiation of treatment is the most effective predictive factor of sustained viral response. Aliment Pharmacol Ther 2004;20:15-22.
12. Wiegand J, Jäckel E, Cornberg M, et al. Long-term follow-up after successful interferon therapy of acute hepatitis C. Hepatology 2004; 40:98-107.
13. Santantonio T, Sinisi E, Guastadisegni A, et al. Natural course of acute hepatitis C: a long-term prospective study. Dig Liver Dis 2003; 35: 104-13.
14. Spada E, Mele A, Berton A, et al. Multispecific T cell response and negative HCV-RNA tests during acute HCV infection are early prognostic factors of spontaneous clearance. Gut 2004; 53:1673-81.
15. Busch MP, Shafer KA. Acute-phase hepatitis C virus infection implications for research, diagnosis and treatment. Clin Infect Dis 2005; 40:959-61.
16. + T cell and cytokine response. Gastroenterology 2001; 121:646-56.
17. Licata A, Di Bona D, Schepis F, et al. When and how to treat acute hepatitis C? J Hepatol 2003; 39:1056-62.